Shelly L. Sayre
The University of Texas Health Science Center at Houston(US)
Publications by Year
Research Areas
Mesenchymal stem cell research, Cardiac Fibrosis and Remodeling, Tissue Engineering and Regenerative Medicine, Substance Abuse Treatment and Outcomes, Cardiovascular Function and Risk Factors
Most-Cited Works
- → Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure(2012)455 cited
- → Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction(2012)387 cited
- → A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial(2021)159 cited
- → Determining predictors of attrition in an outpatient substance abuse program(2002)105 cited
- → Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit + Cardiac Stem Cells As Regenerative Therapy for Heart Failure)(2018)101 cited
- → Cognitive–Behavioral Treatment of Bipolar Disorder and Substance Abuse: A Preliminary Randomized Study(2002)77 cited
- → Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction(2009)77 cited
- → Detailed Analysis of Bone Marrow From Patients With Ischemic Heart Disease and Left Ventricular Dysfunction(2014)66 cited
- → Bone Marrow Characteristics Associated With Changes in Infarct Size After STEMI(2014)59 cited
- LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.(2010)